{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:52:58Z","timestamp":1788274378235,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The burden of hospitalizations and mortality for hemoptysis due to bronchiectasis is not well characterized. The primary outcome of our study was to evaluate in-hospital mortality in patients admitted with hemoptysis and bronchiectasis, as well as the rates of bronchial artery embolization, length of stay, and hospitalization costs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The authors queried the Nationwide Inpatient Sample (NIS) claims database for hospitalizations between 2016 and 2017 using the ICD-10-CM codes for hemoptysis and bronchiectasis in the United States. Multivariable regression was used to evaluate predictors of in-hospital mortality, embolization, length of stay, and hospital costs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 8240 hospitalizations (weighted) for hemoptysis in the United States from 2016 to 2017. The overall in-hospital mortality was 4.5%, but higher in males compared to females. Predictors of in-hospital mortality included undergoing three or more procedures, age, and congestive heart failure. Bronchial artery embolization (BAE) was utilized during 2.1% of hospitalizations and was more frequently used in those with nontuberculous mycobacteria and aspergillus infections, but not pseudomonal infections. The mean length of stay was 6\u00a0days and the median hospitalization cost per patient was USD $9,610. Having comorbidities and procedures was significantly associated with increased length of stay and costs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Hemoptysis is a frequent indication for hospitalization among the bronchiectasis population. In-hospital death occurred in approximately 4.5% of hospitalizations. The effectiveness of BAE in treating and preventing recurrent hemoptysis from bronchiectasis needs to be explored.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-021-01762-6","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T10:03:02Z","timestamp":1638352982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluating hemoptysis hospitalizations among patients with bronchiectasis in the United States: a population-based cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Rachel K.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjani","family":"Somayaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"4","key":"1762_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1378\/chest.10-0099","volume":"138","author":"AE Seitz","year":"2010","unstructured":"Seitz AE, Olivier KN, Steiner CA, MontesdeOca R, Holland SM, Prevots DR. Trends and burden of bronchiectasis\u2212\u2009associated hospitalizations in the United States, 1993\u20132006. Chest. 2010;138(4):944\u20139.","journal-title":"Chest."},{"issue":"4","key":"1762_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","volume":"12","author":"D Weycker","year":"2005","unstructured":"Weycker D, Edelsberg J, Oster G, Tine G. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12(4):205\u20139.","journal-title":"Clin Pulm Med"},{"issue":"4","key":"1762_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/1479972317709649","volume":"14","author":"D Weycker","year":"2017","unstructured":"Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis. 2017;14(4):377\u201384.","journal-title":"Chron Respir Dis"},{"issue":"11","key":"1762_CR4","first-page":"1410","volume":"197","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, et al. Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis. AJRCCM. 2018;197(11):1410\u201320.","journal-title":"AJRCCM"},{"key":"1762_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","volume":"380","author":"C Wong","year":"2012","unstructured":"Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fi brosis bronchiectasis (EMBRACE): A randomised, double-blind, placebo-controlled trial. Lancet. 2012;380:660\u20137.","journal-title":"Lancet"},{"key":"1762_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","volume":"68","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ, Bilton D, De Soyza A, et al. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax. 2013;68:812\u20137.","journal-title":"Thorax"},{"key":"1762_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.2013.2290","volume":"309","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ, Martin ML, McGuckin MA, et al. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA. 2013;309:1260\u20137.","journal-title":"JAMA"},{"key":"1762_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2013.1937","volume":"309","author":"J Altenburg","year":"2013","unstructured":"Altenburg J. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non\u2013cystic fibrosis bronchiectasis. JAMA. 2013;309:1251\u20139.","journal-title":"JAMA"},{"key":"1762_CR9","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629. https:\/\/doi.org\/10.1183\/13993003.00629-2017.","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"1762_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn JS, Floto RA, et al. British thoracic society guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1\u201369. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212463.","journal-title":"Thorax"},{"issue":"4","key":"1762_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, B\u00f6ttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin Infect Dis. 2020;71(4):905\u201313.","journal-title":"Clin Infect Dis"},{"key":"1762_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1159\/000029540","volume":"67","author":"S Osaki","year":"2000","unstructured":"Osaki S, Nakanishi Y, Wataya H, et al. Prognosis of bronchial artery embolization in the management of hemoptysis. Respiration. 2000;67:412.","journal-title":"Respiration"},{"key":"1762_CR13","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.rmed.2006.03.012","volume":"100","author":"PT King","year":"2006","unstructured":"King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006;100:2183\u20139.","journal-title":"Respir Med"},{"key":"1762_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188:647\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1762_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0218492314544310","volume":"23","author":"O Fruchter","year":"2015","unstructured":"Fruchter O, Schneer S, Rusanov V, Belenky A, Kramer MR. Bronchial artery embolization for massive hemoptysis: long term follow-up. Asian Cardiovasc Thorac Ann. 2015;23(1):55\u201360.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"1762_CR16","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.ajem.2017.11.053","volume":"36","author":"J Choi","year":"2018","unstructured":"Choi J, Baik JH, Kim CH, Song SH, Kim SK, Kim M, et al. Long-term outcomes and prognostic factors in patients with mild hemoptysis. Am J Emerg Med. 2018;36:1160\u20135.","journal-title":"Am J Emerg Med"},{"key":"1762_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000446923","volume":"92","author":"M Buscot","year":"2016","unstructured":"Buscot M, Pottier H, Marquette CH, Leroy S. Phenotyping adults with non-cystic fibrosis bronchiectasis: a 10-year cohort study in a French regional university hospital center. Respiration. 2016;92:1\u20138.","journal-title":"Respiration"},{"issue":"5","key":"1762_CR18","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","volume":"151","author":"TR Aksamit","year":"2017","unstructured":"Aksamit TR, O\u2019Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, et al. Adults patients with bronchiectasis. A first look at the US bronchiectasis research registry. Chest. 2017;151(5):982\u201392.","journal-title":"Chest."},{"key":"1762_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1378\/chest.121.3.796","volume":"121","author":"M Antonelli","year":"2002","unstructured":"Antonelli M, Midulla F, Tancredi G, et al. Bronchial artery embolization for the management of nonmassive hemoptysis in cystic fibrosis. Chest. 2002;121:796\u2013801.","journal-title":"Chest"},{"issue":"9","key":"1762_CR20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/0218492316667231","volume":"25","author":"Y Miyano","year":"2017","unstructured":"Miyano Y, Kanzaki M, Onuki T. Bronchial artery embolization: first-line option for managing massive hemoptysis. Asian Cardio Thoracic Ann. 2017;25(9):618\u201322.","journal-title":"Asian Cardio Thoracic Ann"},{"key":"1762_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5152\/dir.2017.16454","volume":"23","author":"A Panda","year":"2017","unstructured":"Panda A, Bhalla AS, Goyal A. Bronchial artery embolization in hemoptysis: a systematic review. Diagn Interv Radiol. 2017;23:307\u201317.","journal-title":"Diagn Interv Radiol"},{"key":"1762_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12890-019-0818-6","volume":"19","author":"PC Goeminne","year":"2019","unstructured":"Goeminne PC, Hernandez F, Diel R, Filonenko A, Hughes R, Juelich F, et al. The economic burden of bronchiectasis \u2013 known and unknown: a systematic review. BMC Pulm Med. 2019;19:54.","journal-title":"BMC Pulm Med"},{"issue":"20","key":"1762_CR23","first-page":"1","volume":"5","author":"C Blanchette","year":"2017","unstructured":"Blanchette C, Noone J, Stone G, Zacherle E, Patel RP, Runken MC, Howden R, Mapel D. Healthcare cost and utilization before and after diagnosis of pseudomonas aeruginosa among patients with non-cystic fibrosis bronchiectasis in the US. Med Sci. 2017;5(20):1\u20138.","journal-title":"Med Sci"},{"issue":"20","key":"1762_CR24","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1001\/jama.2017.17653","volume":"318","author":"R Khera","year":"2017","unstructured":"Khera R, Angraal S, Couch T, Welsh JW, Nallamothu BK, Girotra S, et al. Adherence to methodological standards in research using the national inpatient sample. JAMA. 2017;318(20):2011\u20138.","journal-title":"JAMA"},{"issue":"6","key":"1762_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.rmed.2009.11.021","volume":"104","author":"JD Finklea","year":"2010","unstructured":"Finklea JD, Khan G, Thomas S, Song J, Myers D, Arroliga AC. Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis. Respir Med. 2010;104(6):816\u201321.","journal-title":"Respir Med"},{"key":"1762_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2466-7-17","volume":"7","author":"AH Alzeer","year":"2007","unstructured":"Alzeer AH, Masood M, Jani BS, et al. Survival of brochiectatic patients with respiratory failure in ICU. BMC Pulm Med. 2007;7:17.","journal-title":"BMC Pulm Med"},{"key":"1762_CR27","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1378\/chest.125.5.1815","volume":"125","author":"M Dupont","year":"2004","unstructured":"Dupont M, Gacouin A, Lena H, et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest. 2004;125:1815\u201320.","journal-title":"Chest"},{"key":"1762_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","volume":"4","author":"MJ McDonnell","year":"2016","unstructured":"McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4:969\u201379. https:\/\/doi.org\/10.1016\/S2213-2600(16)30320-4.","journal-title":"Lancet Respir Med"},{"key":"1762_CR29","first-page":"54","volume":"9","author":"MK Lee","year":"2015","unstructured":"Lee MK, Kim S, Yong SJ, Shun KC, Kim HS, Yu T, et al. Moderate hemoptysis: recurrent hemoptysis and mortality according to bronchial artery embolization. Clin Respir J. 2015;9:54\u201364.","journal-title":"Clin Respir J"},{"issue":"6","key":"1762_CR30","doi-asserted-by":"publisher","first-page":"ofaa173","DOI":"10.1093\/ofid\/ofaa173","volume":"7","author":"CE Hannah","year":"2020","unstructured":"Hannah CE, Ford BA, Chung J, Ince D, Wanat KA. Characteristics of nontuberculous mycobacterial infections at a Midwestern tertiary hospital: a retrospective study of 365 patients. Open Forum Infect Dis. 2020;7(6):ofaa173.","journal-title":"Open Forum Infect Dis."},{"issue":"1","key":"1762_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12890-019-0881-z","volume":"19","author":"SH Lee","year":"2019","unstructured":"Lee SH, Lee JH, Chang JH, et al. Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease. BMC Pulm Med. 2019;19(1):117.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"1762_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40121-020-00315-4","volume":"9","author":"A Russo","year":"2020","unstructured":"Russo A, Tiseo G, Falcone M, Menichetti F. Pulmonary aspergillosis: an evolving challenge for diagnosis and treatment. Infect Dis Ther. 2020;9(3):511\u201324. https:\/\/doi.org\/10.1007\/s40121-020-00315-4.","journal-title":"Infect Dis Ther"},{"issue":"7","key":"1762_CR33","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00330-017-5246-5","volume":"28","author":"AJ van der Molen","year":"2018","unstructured":"van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury\u2014Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28(7):2845\u201355.","journal-title":"Eur Radiol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01762-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01762-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01762-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T10:03:41Z","timestamp":1638353021000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01762-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01762-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"1 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study cohort was derived from the 2016 and 2017 National Inpatient Sample (NIS) database from the Healthcare Cost and Utilization Project (HCUP). The NIS is a large publicly available all-payer database produced and maintained by the Agency for Healthcare Research and Quality (Rockville, MD). Therefore, ethics approval and consent was not needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"392"}}